Cabozantinib (active substance) - analogs
Pharmgroups: Antitumor agents - protein kinase inhibitors |
|||||||||
| Prices in pharmacies: Instructions Cabozantinib | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Cabozantinib included in the composition |
Prices in pharmacies |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 71% Sorafenib
- 53% Palbociclib
- 52% Lorlatinib
- 50% Pazopanib
- 50% Nivolumab
- 46% Ixazomib
- 45% Trametinib
- 42% Imatinib
- 42% Regorafenib
- 42% Abemaciclib
- 37% Nintedanib
- 35% Vandetanib
- 32% Nilotinib
- 32% Osimertinib
- 32% Afatinib
- 32% Ribociklib
- 32% Ceritinib
- 32% Vinflunine
- 31% Everolimus
- 30% Dutasteride
- 30% Daratumumab
- 30% Palonosetron
- 30% Venetoclax
- 30% Vinorelbine
- 29% Atezolizumab
- 29% Idarubicin
- 29% Ramucirumab
- 28% Ibrutinib
- 28% Dasatinib
- 28% Akalabrutinib
- 28% Bosutinib
- 28% Talazoparib
- 28% Thyrotropin alfa
- 27% Pembrolizumab
- 27% Leuprorelin
- 27% Netupitant+Palonosetron [Palonosetron]
- 25% Irinotecan
- 24% Cobimetinib
- 24% Vemurafenib
- 24% Aldesleukin
- 24% Dabrafenib
- 23% Vindesine
- 22% Gefitinib
- 21% Dactinomycin
- 21% Carfilzomib
- 21% Pegvisomant
- 20% Radium chloride [223 Ra]
- 20% Abiraterone
- 20% Fosfestrol
- 20% Tramadol
Learn more about the selection of analogues
- The drug has «Cabozantinib» 51 analog by action, the most similar - Sorafenib .
- Medical online service has selected the best substitutes for Cabozantinib based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Cabozantinib to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.